Haemodynamic effects of captopril in acute left ventricular failure complicating myocardial infarction
- PMID: 2441196
- DOI: 10.1097/00005344-198700002-00007
Haemodynamic effects of captopril in acute left ventricular failure complicating myocardial infarction
Abstract
Activation of the renin-angiotensin system in acute myocardial infarction may have important haemodynamic consequences. The effects of captopril were assessed in nine patients with acute left ventricular failure complicating myocardial infarction. Plasma angiotensin II was elevated at 16.8 (3.6) pmol/l (mean [SE]) including high levels in three of four patients in the absence of any previous therapy, including diuretics. Repeated low doses of captopril were administered to reduce pulmonary capillary wedge pressure less than 14 mm Hg or to a maximum total dose of 25 mg. Right atrial pressure fell from 12.4 (0.9) to 9.4 (0.7) mm Hg p less than 0.001, pulmonary arterial pressure from 32.7 (3) to 26.4 (2.2) p = 0.01, and pulmonary capillary wedge pressure from 25.7 (2.9) to 19.9 (2.2) p = 0.01. Despite a fall in systemic vascular resistance from 1,540 (110) to 1,330 (76) dyn/s/cm5, and mean arterial pressure from 84.8 (3.9) to 76.7 (2.7) p = 0.001, changes in cardiac output were small: 3.8 (0.3) to 4.2 (0.3) NS. Angiotensin II fell in all patients even after only 3.125 mg to a mean of 3.6 (1.0). These improvements occurred whether basal angiotensin II was elevated or normal, and in the presence or absence of diuretic therapy. At 24 hours, seven patients received captopril in the maximum titrated dose of the previous day. Haemodynamic changes at one hour were of similar magnitude to those during incremental dosing. These results suggest that reduction of angiotensin II exerts beneficial haemodynamic effects in heart failure complicating acute myocardial infarction.
Similar articles
-
Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.Postgrad Med J. 1986;62 Suppl 1:164-6. Postgrad Med J. 1986. PMID: 3534855
-
Immediate effects of captopril in acute left ventricular failure secondary to myocardial infarction.Eur J Clin Invest. 1981 Oct;11(5):369-73. doi: 10.1111/j.1365-2362.1981.tb01998.x. Eur J Clin Invest. 1981. PMID: 6800808
-
Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.Br Heart J. 1983 Jan;49(1):65-76. doi: 10.1136/hrt.49.1.65. Br Heart J. 1983. PMID: 6336940 Free PMC article.
-
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.Drugs. 1984 Aug;28(2):144-69. doi: 10.2165/00003495-198428020-00004. Drugs. 1984. PMID: 6205842 Review.
-
Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.Am J Cardiol. 1976 Feb;37(2):263-8. doi: 10.1016/0002-9149(76)90322-2. Am J Cardiol. 1976. PMID: 1108634 Review.
Cited by
-
Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.Drugs. 1992 May;43(5):637-50. doi: 10.2165/00003495-199243050-00002. Drugs. 1992. PMID: 1379144 Review.
-
Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.Br Heart J. 1994 Nov;72(5):422-7. doi: 10.1136/hrt.72.5.422. Br Heart J. 1994. PMID: 7818958 Free PMC article. Clinical Trial.
-
The use of angiotensin-converting enzyme inhibitors in congestive heart failure.Cardiovasc Drugs Ther. 1989 Dec;3(6):883-90. doi: 10.1007/BF01869576. Cardiovasc Drugs Ther. 1989. PMID: 2487549 Review.
-
The renin-angiotensin system and coronary vasomotion.Heart. 1996 Nov;76(3 Suppl 3):45-52. doi: 10.1136/hrt.76.3_suppl_3.45. Heart. 1996. PMID: 8977364 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous